Open Access Article
Xingang Liua,
Min Wua,
Meng Wangb,
Yukun Duana,
ChiUyen Phanc,
Guobin Qia,
Guping Tang*c and
Bin Liu*ad
aDepartment of Chemical and Biomolecular Engineering, National University of Singapore, Engineering Drive 4, 117585, Singapore. E-mail: cheliub@nus.edu.sg
bDepartment of Hepatobiliary and Pancreatic Surgery, First Affiliated Hospital, Zhejiang University, School of Medicine, Hangzhou 310003, China
cDepartment of Chemistry, Zhejiang University, Hangzhou 310028, China. E-mail: tangguping@zju.edu.cn
dJoint School of National University of Singapore and Tianjin University, International Campus of Tianjin University, Binhai New City, Fuzhou 350207, China
First published on 13th February 2026
Correction for ‘Metabolically engineered bacteria as light-controlled living therapeutics for anti-angiogenesis tumor therapy’ by Xingang Liu et al., Mater. Horiz., 2021, 8, 1454–1460, https://doi.org/10.1039/D0MH01582B.
In addition, incorrect images were shown in the Supplementary Information (SI) for Fig. S17 (SV(+L), 1 d) and S21 (Heart, SE@MA and SV@MA). The SI available online has now been updated to show the correct images.
The authors confirm that these errors do not affect the conclusions of the article.
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
| This journal is © The Royal Society of Chemistry 2026 |